Search research articles
Contact Us
Filters
Showing results (351-360 of 716) with videos related to
Page
of 72
Sort By:
International Journal of Cardiology
|
May 14, 2019
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes
Patrícia O Guimarães, Eric D Peterson, Susanna R Stevens, et al.
Diabetes, Obesity & Metabolism
|
March 3, 2020
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
November 16, 2016
Left Atrial Dysfunction in the Pathogenesis of Cryptogenic Stroke: Novel Insights from Speckle-Tracking Echocardiography
Darryl P Leong, Emer Joyce, Philippe Debonnaire, et al.
Biomaterials
|
October 28, 2023
Conductive electrospun polymer improves stem cell-derived cardiomyocyte function and maturation
Gisselle Gonzalez, Aileena C Nelson, Alyssa R Holman, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
13-HODE and 13-HOTrE, Present in the Traditional Chinese Medicine Herbal Extract di gu pi, Selectively Inhibit Platelet Function
Dylan Simpson, Eliana Botta, Pooja Yalavarthi, et al.
American Heart Journal
|
May 8, 2026
Serial Assessment of NT-proBNP and High-Sensitivity Cardiac Troponin with Glucagon-Like Peptide-1 Receptor Agonist Therapy in Type 2 Diabetes: Insights from EXSCEL
Veraprapas Kittipibul, Maggie Nguyen, Paul Welsh, et al.
Tissue Antigens
|
February 13, 2001
Identification of HLA-A*2306
S T Cox, A J McWhinnie, F A Baker, et al.
BMJ Open
|
December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocol
Catherine Angwin, Caroline Jenkinson, Angus Jones, et al.
Tissue Antigens
|
July 30, 2002
Identification of HLA-B*1566
S T Cox, B Prokupek, F Baker, et al.
Applied and Environmental Microbiology
|
August 28, 2016
Bacterial Populations Associated with Smokeless Tobacco Products
Jing Han, Yasser M Sanad, Joanna Deck, et al.
Page
of 72
Search research articles
Search
Showing results (351-360 of 716) with videos related to
Sort By:
Page
of 72
International Journal of Cardiology
|
May 14, 2019
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes
Patrícia O Guimarães, Eric D Peterson, Susanna R Stevens, et al.
Diabetes, Obesity & Metabolism
|
March 3, 2020
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
November 16, 2016
Left Atrial Dysfunction in the Pathogenesis of Cryptogenic Stroke: Novel Insights from Speckle-Tracking Echocardiography
Darryl P Leong, Emer Joyce, Philippe Debonnaire, et al.
Biomaterials
|
October 28, 2023
Conductive electrospun polymer improves stem cell-derived cardiomyocyte function and maturation
Gisselle Gonzalez, Aileena C Nelson, Alyssa R Holman, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
13-HODE and 13-HOTrE, Present in the Traditional Chinese Medicine Herbal Extract di gu pi, Selectively Inhibit Platelet Function
Dylan Simpson, Eliana Botta, Pooja Yalavarthi, et al.
American Heart Journal
|
May 8, 2026
Serial Assessment of NT-proBNP and High-Sensitivity Cardiac Troponin with Glucagon-Like Peptide-1 Receptor Agonist Therapy in Type 2 Diabetes: Insights from EXSCEL
Veraprapas Kittipibul, Maggie Nguyen, Paul Welsh, et al.
Tissue Antigens
|
February 13, 2001
Identification of HLA-A*2306
S T Cox, A J McWhinnie, F A Baker, et al.
BMJ Open
|
December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocol
Catherine Angwin, Caroline Jenkinson, Angus Jones, et al.
Tissue Antigens
|
July 30, 2002
Identification of HLA-B*1566
S T Cox, B Prokupek, F Baker, et al.
Applied and Environmental Microbiology
|
August 28, 2016
Bacterial Populations Associated with Smokeless Tobacco Products
Jing Han, Yasser M Sanad, Joanna Deck, et al.
Page
of 72